Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm
BackgroundResearch trials have shown improved short-term outcome with drug-eluting stents (DES) over bare metal stents (BMS) in saphenous vein graft (SVG) percutaneous coronary intervention (PCI), primarily by reducing target vessel revascularization (TVR) for in-stent restenosis. We compared the ou...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Touch Medical Media
2016-05-01
|
Series: | Heart International |
Online Access: | http://www.heart-int.com/Attach/1B069907-E827-40E4-B6B2-A9DEBF6EDDB0/0D901FE4-6202-4EA6-85A6-7749C29F66A7 |
id |
doaj-774c16739ecb474881572dab06827b16 |
---|---|
record_format |
Article |
spelling |
doaj-774c16739ecb474881572dab06827b162020-11-25T00:07:22ZengTouch Medical MediaHeart International1826-18682036-25792016-05-011110010.5301/heartint.5000228Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mmOliver P. GuttmannDaniel A. JonesKassem A. SafwanSean GallagherKrishnaraj S. RathodSteve HamshereElliot J. SmithAjay K. JainAnthony MathurAndrew WraggCharles J. KnightRoshan WeerackodyBackgroundResearch trials have shown improved short-term outcome with drug-eluting stents (DES) over bare metal stents (BMS) in saphenous vein graft (SVG) percutaneous coronary intervention (PCI), primarily by reducing target vessel revascularization (TVR) for in-stent restenosis. We compared the outcomes in patients undergoing SVG stent implantation treated with DES or BMS. In exploratory analyses we investigated the influence of stent generation and diameter.MethodsData were obtained from a prospective database of 657 patients who underwent PCI for SVG lesions between 2003 and 2011. A total of 344 patients had PCI with BMS and 313 with DES. Propensity scores were developed based on 15 observed baseline covariates in a logistic regression model with stent type as the dependent variable. The nearest-neighbour-matching algorithm with Greedy 5-1 Digit Matching was used to produce two patient cohorts of 313 patients each. We assessed major adverse cardiac events (MACE) out to a median of 3.3 years (interquartile range: 2.1-4.1). MACE was defined as all-cause mortality, myocardial infarction (MI), TVR and stroke.ResultsThere was a significant difference in MACE between the two groups in favour of DES (17.9% DES vs. 31.2% BMS group; p = 0.0017) over the 5-year follow-up period. MACE was driven by increased TVR in the BMS group. There was no difference in death, MI or stroke. Adjusted Cox analysis confirmed a decreased risk of MACE for DES compared with BMS 0.75 (95% confidence interval (CI) 0.52-0.94), with no difference in the hazard of all-cause mortality (hazard ratio: 1.08; 95% CI: 0.77-1.68). However, when looking at stent diameters greater than 4 mm, no difference was seen in MACE rates between BMS and DES.ConclusionsOverall in our cohort of patients who had PCI for SVG disease, DES use resulted in lower MACE rates compared with BMS over a 5-year follow-up period; however, for stent diameters over 4 mm no difference in MACE rates was seen.http://www.heart-int.com/Attach/1B069907-E827-40E4-B6B2-A9DEBF6EDDB0/0D901FE4-6202-4EA6-85A6-7749C29F66A7 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Oliver P. Guttmann Daniel A. Jones Kassem A. Safwan Sean Gallagher Krishnaraj S. Rathod Steve Hamshere Elliot J. Smith Ajay K. Jain Anthony Mathur Andrew Wragg Charles J. Knight Roshan Weerackody |
spellingShingle |
Oliver P. Guttmann Daniel A. Jones Kassem A. Safwan Sean Gallagher Krishnaraj S. Rathod Steve Hamshere Elliot J. Smith Ajay K. Jain Anthony Mathur Andrew Wragg Charles J. Knight Roshan Weerackody Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm Heart International |
author_facet |
Oliver P. Guttmann Daniel A. Jones Kassem A. Safwan Sean Gallagher Krishnaraj S. Rathod Steve Hamshere Elliot J. Smith Ajay K. Jain Anthony Mathur Andrew Wragg Charles J. Knight Roshan Weerackody |
author_sort |
Oliver P. Guttmann |
title |
Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm |
title_short |
Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm |
title_full |
Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm |
title_fullStr |
Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm |
title_full_unstemmed |
Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm |
title_sort |
drug-eluting stents appear superior to bare metal stents for vein-graft pci in vessels up to a stent diameter of 4 mm |
publisher |
Touch Medical Media |
series |
Heart International |
issn |
1826-1868 2036-2579 |
publishDate |
2016-05-01 |
description |
BackgroundResearch trials have shown improved short-term outcome with drug-eluting stents (DES) over bare metal stents (BMS) in saphenous vein graft (SVG) percutaneous coronary intervention (PCI), primarily by reducing target vessel revascularization (TVR) for in-stent restenosis. We compared the outcomes in patients undergoing SVG stent implantation treated with DES or BMS. In exploratory analyses we investigated the influence of stent generation and diameter.MethodsData were obtained from a prospective database of 657 patients who underwent PCI for SVG lesions between 2003 and 2011. A total of 344 patients had PCI with BMS and 313 with DES. Propensity scores were developed based on 15 observed baseline covariates in a logistic regression model with stent type as the dependent variable. The nearest-neighbour-matching algorithm with Greedy 5-1 Digit Matching was used to produce two patient cohorts of 313 patients each. We assessed major adverse cardiac events (MACE) out to a median of 3.3 years (interquartile range: 2.1-4.1). MACE was defined as all-cause mortality, myocardial infarction (MI), TVR and stroke.ResultsThere was a significant difference in MACE between the two groups in favour of DES (17.9% DES vs. 31.2% BMS group; p = 0.0017) over the 5-year follow-up period. MACE was driven by increased TVR in the BMS group. There was no difference in death, MI or stroke. Adjusted Cox analysis confirmed a decreased risk of MACE for DES compared with BMS 0.75 (95% confidence interval (CI) 0.52-0.94), with no difference in the hazard of all-cause mortality (hazard ratio: 1.08; 95% CI: 0.77-1.68). However, when looking at stent diameters greater than 4 mm, no difference was seen in MACE rates between BMS and DES.ConclusionsOverall in our cohort of patients who had PCI for SVG disease, DES use resulted in lower MACE rates compared with BMS over a 5-year follow-up period; however, for stent diameters over 4 mm no difference in MACE rates was seen. |
url |
http://www.heart-int.com/Attach/1B069907-E827-40E4-B6B2-A9DEBF6EDDB0/0D901FE4-6202-4EA6-85A6-7749C29F66A7 |
work_keys_str_mv |
AT oliverpguttmann drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT danielajones drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT kassemasafwan drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT seangallagher drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT krishnarajsrathod drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT stevehamshere drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT elliotjsmith drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT ajaykjain drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT anthonymathur drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT andrewwragg drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT charlesjknight drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm AT roshanweerackody drugelutingstentsappearsuperiortobaremetalstentsforveingraftpciinvesselsuptoastentdiameterof4mm |
_version_ |
1725418711710433280 |